Stockscreener 앱 받기
1.91
1.06%
0.02
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Enterprise value to EBITDA forward of Stereotaxis, Inc. – LS:A1J09L - TradingView
Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan
Director at Stereotaxis (STXS) receives 43,103-share equity grant - Stock Titan
Stereotaxis (STXS) director awarded 43,103 restricted share units, holding 1,035,560 shares - Stock Titan
Robotics redefine electrophysiology, Stereotaxis, Inc. explores in latest podcast - Traders Union
STXS Q1 2026 Earnings: EPS Misses Estimates as Stock SlipsWeak Earnings Momentum - dars.gov.et
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) - Yahoo Finance
Stereotaxis Inc. (STXS) Holds Near Support Amidst Low VolatilityMomentum Stock Picks - dars.gov.et
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2000 Value Benchmark - marketscreener.com
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Price to earnings forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
STXSStereotaxis Inc Options - Finviz
Stereotaxis, Inc. Hits New 52-Week Low at $1.60 Amid Decline - MarketsMojo
8 Most Promising Robotics Stocks Now - Insider Monkey
Enterprise value to EBIT forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Enterprise value to revenue forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView
Stereotaxis, Inc. Actuals & Estimates (AMEX:STXS) - TradingView
Stereotaxis, Inc. Actuals & Estimates (DUS:RJR1) - TradingView
STXS Forecast — Price Target — Prediction for 2027 - TradingView
Stereotaxis | 4: Statement of changes in beneficial ownership of securities-Officer Peery Kimberly R. - Moomoo
Stereotaxis Inc (STXS) Institutional Confidence - TradingKey
Stereotaxis, Inc. publishes new robotics case study in electrophysiology - Traders Union
Top Endovascular Robotic Systems Companies Driving the Future of Vascular Care - Fortune Business Insights
STXS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stereotaxis, Inc. unveils online demo platform for advanced robotic cath lab - Traders Union
Stereotaxis Inc (STXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Stereotaxis Inc (STXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stereotaxis Inc (STXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stereotaxis Inc (STXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Stereotaxis Inc (STXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stereotaxis Inc (STXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stereotaxis Inc (STXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Stereotaxis Inc (STXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stereotaxis, Inc. unveils Synchrony system to enhance cath lab workflow with single high resolution display - Traders Union
Q1 2026 Stereotaxis Inc Earnings Call Transcript - GuruFocus
Stereotaxis eyes billions in market opportunity with Robocath takeover - MSN
MAGiC system delivers enhanced precision and control in arrhythmia care - Traders Union
Stereotaxis (STXS) Stock Price, News & Analysis $STXS - MarketBeat
Stereotaxis Inc (NYSE: STXS) Share Price, STXS Stock News, STXS Share Price & Updates - Kalkine
Stereotaxis, Inc. cites 500 peer-reviewed publications on robotic electrophysiology safety and efficacy - Traders Union
Stereotaxis, Inc. unveils remote access technology in cardiology test drive event - Traders Union
Citizens reiterates Stereotaxis stock rating on growth outlook By Investing.com - Investing.com South Africa
Citizens reiterates Stereotaxis stock rating on growth outlook - Investing.com
STXS Q1 2026 Earnings: Wider-than-Expected Loss Amidst Revenue ChallengesFree Cash Flow Trends - newsline.com
STXS Q1 2026 Earnings: EPS Misses Estimates as Losses WidenEarnings Trend Analysis - newsline.com
Stereotaxis Inc. (STXS) Slips 4.8% – Testing Key Support at $1.88TPO Profile - The Legal Advocate
Stereotaxis Inc. (STXS) Faces Selling Pressure as Shares Slide to $1.98Ratio Spread Trade - The Legal Advocate
Stereotaxis, Inc. advances robotic precision to transform patient care - Traders Union
Stereotaxis stock up on first US MAGIC procedures post approval - MSN
Stereotaxis Inches Upwards as Shares Approach Resistance at $2.02KAMA Signal - The Legal Advocate
Stereotaxis (STXS) Edges Higher: Navigating the Robotics Sector with Modest GainsVolatility Term Structure - Newser
Stereotaxis Emerges as Notable Oversold Play in AI Sector with Over 120 Percent Implied Upside - HarianBasis.co
Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why - Insider Monkey
Stereotaxis Inc. (STXS) Edges Higher as Stock Tests Key Resistance Near $2.02Shared Buy Zones - Newser
STXS Q1 2026 Earnings: Larger-Than-Expected Loss as Company Continues Strategic TransitionROA Comparison - Newser
5 Most Oversold AI Stocks to Buy According to Analysts - Insider Monkey
2.28%
2.50%
자본화:
|
볼륨(24시간):